Overview of Knowledge and Practices Among Healthcare Professionals Treating Eating Disorders (TCA)

January 5, 2026 updated by: University Hospital, Strasbourg, France

Overview of Knowledge and Practices Among Healthcare Professionals Treating Eating Disorders in the Perinatal Context in Alsace, France

Perinatal psychiatry is a psychiatric specialty that has been developing for several years. This perinatal period is crucial for bio-psycho-affective development.

Eating disorders are among the most common disorders in psychiatry. Women who have experienced or currently experience eating disorders may exhibit a relapse, stabilization, or improvement in these behaviors, with direct consequences for their baby's development.

Although eating disorders have been extensively studied in adolescents and adults, the perinatal period remains less explored.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

269

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • France
      • Strasbourg, France, 67091
        • Recruiting
        • Centre Psychothérapique pour Enfants et Adolescents - CHU de Strasbourg - France
        • Contact:
        • Contact:
        • Principal Investigator:
          • Sarah SANANES, MD
        • Principal Investigator:
          • Laetitia SIBILLE, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Psychiatrists, midwives, gynecologists, general practitioners, psychologists, maternal and child health professionals (PMI) practicing in Alsace

Description

Inclusion Criteria:

  • Psychiatrists, midwives, gynecologists, general practitioners, psychologists, maternal and child health professionals (PMI),
  • Practicing in Alsace
  • Agreeing to participate in the survey

Exclusion Criteria:

  • Healthcare professionals who do not treat patients in a perinatal context.
  • Professionals outside Alsace

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overview of healthcare professionals' practices concerning eating disorders in the perinatal period
Time Frame: Up to 12 months
The study consists of an overview of healthcare professionals' practices concerning eating disorders in the perinatal period in the Alsace region of France
Up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Strasbourg, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 25, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 25, 2026

Study Registration Dates

First Submitted

January 5, 2026

First Submitted That Met QC Criteria

January 5, 2026

First Posted (Actual)

January 14, 2026

Study Record Updates

Last Update Posted (Actual)

January 14, 2026

Last Update Submitted That Met QC Criteria

January 5, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 9769 (Fred Hutch/University of Washington Cancer Consortium)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Eating Disorders

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe